Final Report - MOL CANCER MED (Developing molecular medicines for cancer in the post-genome era)
Project ID: 502943Funded under: FP6-LIFESCIHEALTH
This is the final report for the MOL CANCER MED project which was designed with the primary strategic aim of assembling the necessary critical mass of collaborating researchers engaged in telomerase, telomere and translational cancer research within the European Union. The report covers the aims, objectives and achievements before providing an extensive provisional list of all project publications.
Download application/zip (54244)
Record Number: 12668 / Last updated on: 2011-04-14